Page 16 - Oche News Today

When is the last time that you weren’t sleeping that you were in total silence? That sounds crazy, right? Who needs silence when there’s a phone nearby and ear buds

Psagot Value Holdings Ltd. Israel grew its stake in shares of Chemed Co. (NYSE:CHE – Free Report) by 39.5% in the first quarter, HoldingsChannel.com reports. The firm owned 600 shares of the company’s stock after purchasing an additional 170 shares during the period. Psagot Value Holdings Ltd. Israel’s holdings in Chemed were worth $314,000 as […]

As China stocks continue to fall, investors may want to ensure their emerging markets exposure diversifies away from the country.

Roche is open to making big acquisitions if they make "sense", Chief Executive Thomas Schinecker said, with the Swiss drugmaker unencumbered by its $20.7 billion deal last year to buy back its shares from Novartis. "Of course, we also look externally for opportunities," Schinecker, who became Roche CEO in March, told Swiss newspaper NZZ Am Sonntag in an article to be published on Sunday. "If it makes scientific and financial sense, we can also imagine a large acquisiti...

A young man was yelling “Diane! Diane!” from the crowd behind me as I walked with Natalie, Elizabeth and Blake toward Memorial Stadium in Lincoln on Wednesday night. It was

The small molecule drug alectinib (Alecensa) developed by the big pharma company Roche has improved disease-free survival in patients with a specific form of non-small cell lung cancer (NSCLC) when delivered as an adjuvant therapy in a phase 3 trial.

Soobben says his drawings have angered some politicians who are not willing to help him keep the school in SA

Setyembre 3, 2023 - Linggo Metro Manila Turf Club - Tanauan City, Batangas.

StockNews.com upgraded shares of Chemed (NYSE:CHE – Free Report) from a hold rating to a buy rating in a research note published on Wednesday morning. Separately, Royal Bank of Canada decreased their price objective on shares of Chemed from $610.00 to $576.00 and set an outperform rating for the company in a research report on […]

UK's NHS introduces groundbreaking cancer treatment injection, potentially reducing treatment times for eligible patients by three quarters